Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15576 - 15600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	TUBD1	51174	upregulated	Bortezomib results in increased expression of TUBD1 mRNA	17q23.1	A21434
Bortezomib	Approved Investigational	TXLNGY	246126	upregulated	Bortezomib results in increased expression of TXLNGY mRNA	Yq11.222-q11.223	A21434
Bortezomib	Approved Investigational	TXNDC9	10190	upregulated	Bortezomib results in increased expression of TXNDC9 mRNA	2q11.2	A21434
Bortezomib	Approved Investigational	U2AF2	11338	downregulated	Bortezomib results in decreased expression of U2AF2 mRNA	19q13.43	A21434
Bortezomib	Approved Investigational	UBR3	130507	upregulated	Bortezomib results in increased expression of UBR3 mRNA	2q31.1	A21434
Bortezomib	Approved Investigational	UBXN4	23190	upregulated	Bortezomib results in increased expression of UBXN4 mRNA	2q21.3	A21434
Bortezomib	Approved Investigational	UNC93B1	81622	downregulated	Bortezomib results in decreased expression of UNC93B1 mRNA	11q13.2	A21434
Bortezomib	Approved Investigational	UNKL	64718	upregulated	Bortezomib results in increased expression of UNKL mRNA	16p13.3	A21434
Bortezomib	Approved Investigational	UQCRB	7381	upregulated	Bortezomib results in increased expression of UQCRB mRNA	8q22.1	A21434
Bortezomib	Approved Investigational	USP45	85015	upregulated	Bortezomib results in increased expression of USP45 mRNA	6q16.2	A21434
Bortezomib	Approved Investigational	USP53	54532	upregulated	Bortezomib results in increased expression of USP53 mRNA	4q26	A21434
Bortezomib	Approved Investigational	VASP	7408	downregulated	Bortezomib results in decreased expression of VASP mRNA	19q13.32	A21434
Bortezomib	Approved Investigational	VCP	7415	upregulated	Bortezomib results in increased expression of VCP mRNA	9p13.3	A21434
Bortezomib	Approved Investigational	VDAC1	7416	downregulated	Bortezomib results in decreased expression of VDAC1 mRNA	5q31.1	A21434
Bortezomib	Approved Investigational	VEGFB	7423	downregulated	Bortezomib results in decreased expression of VEGFB mRNA	11q13.1	A21437
Bortezomib	Approved Investigational	VEGFB	7423	upregulated	Bortezomib results in increased expression of VEGFB mRNA	11q13.1	A21438
Bortezomib	Approved Investigational	VEZT	55591	upregulated	Bortezomib results in increased expression of VEZT mRNA	12q22	A21434
Bortezomib	Approved Investigational	WBP4	11193	upregulated	Bortezomib results in increased expression of WBP4 mRNA	13q14.11	A21434
Bortezomib	Approved Investigational	WDR44	54521	upregulated	Bortezomib results in increased expression of WDR44 mRNA	Xq24	A21434
Bortezomib	Approved Investigational	WDR48	57599	upregulated	Bortezomib results in increased expression of WDR48 mRNA	3p22.2	A21434
Bortezomib	Approved Investigational	WDR74	54663	upregulated	Bortezomib results in increased expression of WDR74 mRNA	11q12.3	A21434
Bortezomib	Approved Investigational	WDR82	80335	upregulated	Bortezomib results in increased expression of WDR82 mRNA	3p21.2	A21434
Bortezomib	Approved Investigational	WT1	7490	downregulated	Bortezomib results in decreased expression of WT1 mRNA	11p13	A20714 A21434 A21451
Bortezomib	Approved Investigational	XAF1	54739	downregulated	Bortezomib results in decreased expression of XAF1 mRNA	17p13.2	A21434
Bortezomib	Approved Investigational	XCL1	6375	downregulated	Bortezomib results in decreased expression of XCL1 mRNA	1q24.2	A21434

Displaying entries 15576 - 15600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability